The Kids’ Cancer Project is a leading national charity funding childhood cancer research. With generous support more than $27m has been invested in projects, including the institute. It is committed to 100% survival for children with cancer while minimising the potential harmful effects of treatment.
The Apex Foundation helped found Children’s Cancer Institute in 1984 with a $1 million donation to establish its first laboratories. The Apex Foundation provides generous annual grants for our research and supports our Histone Modification Group.
Cure Brain Cancer Foundation is the largest dedicated fundraiser for brain cancer research in Australia. The Foundation funds a research program that focuses on finding more effective, less invasive new ways to treat the cancer.
The Live for Lily Foundation fundraise in memory of Lily Hester who lost her battle with childhood cancer in 2013, to support the delivery of the national Zero Childhood Cancer personalised medicine program being led by Children’s Cancer Institute.
The RCD Fund supports brain cancer research, care and development in memory of the ‘awesome’ Robert ‘Connor’ Dawes. After Connor lost a 16-month battle to ependymoma, the fund was created to keep his ‘Aeternum Fortis’ (eternal strength) spirit alive.
The Marian and EH Flack Trust has provided funding for Children’s Cancer Institute to purchase imaging systems that enable our researchers to visualise individual cancer cells to identify critical genes and proteins.
The Fairbridge Foundation has provided funding for Children’s Cancer Institute to purchase the Tecan Digital Compound Dispenser D300 – a vital piece of research equipment.
The Roth Charitable Foundation generously provides funding, in memory of Charmaine Roth’s late mother Maisie Winkler, for the operational costs to support skilled scientists completing drug screening for new improved treatments for childhood cancer in our Drug Discovery Centre.
The ISG Foundation provides funding to progress our research towards a cure for mixed-lineage leukaemia (MLL) – a cancer that mostly affects infants and has very poor survival rates.
The Lin Huddleston Charitable Foundation supports the work of the Institute through our research support services, which are vital to ensure all researchers have the necessary equipment to carry out their work.
The Profield Foundation is a long-term partner that provides funding to establish a unique drug discovery program aimed at developing better and safer drugs for childhood cancer – in particular, neuroblastoma.
The Reuben Pelerman Benevolent Foundation funds Children’s Cancer Institute’s Minimal Residual Disease (MRD) Group, which focuses on examining acute lymphoblastic leukaemia (ALL) samples using advanced molecular diagnostic techniques.
The Ross Trust funds two of Children’s Cancer Institute’s vital programs that focus on leukaemia.